We are live on
!
Find out more
HH
HSG Holding Portfolio holdings
AUM
$1.62B
1-Year Est. Return
5.91%
This Fund
S&P 500
This Quarter
Est. Return
+11.04%
1 Year Est. Return
-5.91%
3 Year Est. Return
+10.58%
5 Year Est. Return
-52.45%
10 Year Est. Return
+717.11%
AUM
$933M
AUM Growth
+$58.3M
(+6.7%)
Cap. Flow
-$7.07M
Cap. Flow
% of AUM
-0.76%
Top 10 Holdings %
Top 10 Hldgs %
93.51%
Holding
21
New
1
Increased
1
Reduced
2
Closed
1
Top Buys
| 1 |
Structure Therapeutics
GPCR
|
+$34.3M |
| 2 |
TOUR
Tuniu
TOUR
|
+$6.67M |
Top Sells
| 1 |
Zai Lab
ZLAB
|
+$19.3M |
| 2 |
KE Holdings
BEKE
|
+$14.7M |
| 3 |
Roivant Sciences
ROIV
|
+$14.1M |
Sector Composition
| 1 | Technology | 25.18% |
| 2 | Communication Services | 21.81% |
| 3 | Consumer Discretionary | 20.32% |
| 4 | Financials | 10.97% |
| 5 | Healthcare | 10.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Kanzhun
BZ
$6.66B
| $203M | 21.75% |
13,367,284
| – | – |
|
2
Full Truck Alliance
YMM
$9.48B
| $195M | 20.9% |
27,681,263
| – | – |
|
3
Pinduoduo
PDD
$120B
| $156M | 16.75% |
1,592,510
| – | – |
|
|
4
KE Holdings
BEKE
$19.3B
| $75.2M | 8.07% |
4,847,541
-923,770
| -16% | -$14.7M |
|
5
Futu Holdings
FUTU
$13.3B
| $61.1M | 6.56% |
1,057,644
| – | – |
|
|
6
Structure Therapeutics
GPCR
$3.45B
| $53.7M | 5.76% |
+1,065,226
| New | +$34.3M |
|
|
NOAH
7
Noah Holdings
NOAH
$610M
| $41.2M | 4.41% |
3,300,000
| – | – |
|
8
Bitdeer Technologies
BTDR
$2.61B
| $38.9M | 4.18% |
4,039,502
| – | – |
|
9
TH International
THCH
$57M
| $26.3M | 2.82% |
2,900,606
| – | – |
|
|
DDL
10
Dingdong
DDL
$496M
| $21.7M | 2.33% |
11,141,166
| – | – |
|
11
Beam Therapeutics
BEAM
$2.83B
| $19.1M | 2.05% |
796,089
| – | – |
|
|
12
Roivant Sciences
ROIV
$24.8B
| $15.7M | 1.69% |
1,345,839
-1,249,999
| -48% | -$14.1M |
|
|
TOUR
13
Tuniu
TOUR
$55.2M
| $7.1M | 0.76% |
591,913
+480,802
| +433% | +$6.67M |
|
|
COE
14
51Talk Online Education Group
COE
$96M
| $5.87M | 0.63% |
667,223
| – | – |
|
15
Lyell Immunopharma
LYEL
$326M
| $4.48M | 0.48% |
152,300
| – | – |
|
|
BRNS
16
Barinthus Biotherapeutics
BRNS
$22.7M
| $4.39M | 0.47% |
1,420,473
| – | – |
|
|
ADAG
17
Adagene
ADAG
$237M
| $2.06M | 0.22% |
1,343,364
| – | – |
|
|
SLAI
18
SOLAI Ltd ADS
SLAI
| $964K | 0.1% |
50,061
| – | – |
|
|
JT
19
DELISTED
Jianpu Technology Inc. American Depositary Shares, each representing twenty Class A Ordinary Shares
JT
| $619K | 0.07% |
624,998
| – | – |
|
|
BNR
20
Burning Rock Biotech
BNR
$105M
| $206K | 0.02% |
21,212
| – | – |
|
|
21
Zai Lab
ZLAB
$2.28B
| – | – |
-694,634
| Closed | -$19.3M |
|
Similar funds
TLFA
KCM
IPW
WIC
BW
KCM
PRA
MIM
HSG Holding's Q3 2023 Portfolio in Review
As of Q3 2023, HSG Holding held 21 positions worth $933M, up 6.7% from $874M the previous quarter. Its ten largest holdings account for 94% of the portfolio.
HSG Holding's Q3 2023 filing shows 1 new, 1 increased, 2 reduced and 1 closed positions. Its largest new stake was Structure Therapeutics: 1,065,226 shares worth $53.7M. The largest sale was Zai Lab, an estimated $19.3M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Communication Services and Consumer Discretionary.
- HSG Holding's largest Q3 2023 buy was Structure Therapeutics: 1,065,226 shares worth $53.7M.
- HSG Holding added most to Tuniu in Q3 2023, an estimated $6.67M increase.
- HSG Holding's biggest Q3 2023 reduction was KE Holdings, cutting an estimated $14.7M.
- HSG Holding fully exited Zai Lab in Q3 2023, selling an estimated $19.3M.
- HSG Holding's ten largest holdings make up 94% of its $933M portfolio in Q3 2023.
- HSG Holding opened 1 new position and closed 1 in Q3 2023.
- HSG Holding's portfolio value rose 6.7% quarter-over-quarter to $933M.
Based on HSG Holding's 13F filing for Q3 2023, filed 14 Nov 2023.